HomeCONGRESS

CONGRESS

AHA 2023 | ORBITA-2: PCI vs. Placebo in Stable Angina for Symptom Reduction

In patients with stable chronic angina, percutaneous coronary intervention (PCI) is often conducted to relieve symptoms. However,...

AHA 2023 | Use of Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Subclinical atrial fibrillation (AF), generally asymptomatic and of short duration, often requires continuous long-term monitoring using pacemakers...

AHA 2023

Here are the most important scientific articles of the AHA 2023 Congress. If you cannot view the articles,...

Cardiointerv 2023 Soon to Be Held

The Latin American Society of Interventional Cardiology is inviting our entire community to take part in Cardiointerv...

See the Presentations of the 13th ProEducar Fellows Course

  During SOLACI-SBHCI 2023, our traditional education program for young interventionists ProEducar Fellows Course was held.  Discover the presentations of the prestigious...

18th Colombian Congress of Hemodynamics and Cardiovascular Interventionism to Start This Week

On November 9 thru 11, 2023, the 18th Colombian Congress of Hemodynamics and Cardiovascular Interventionism will be...

November 17 and 18: SOVECI 20th Annual Meeting, 2023

We invite the entire community to take part in the annual meeting of the Venezuelan Society of...

TCT 2023 | CLASP IID Study 1-Year Results: PASCAL vs. MITRACLIP for Degenerative Mitral Regurgitation

The negative impact of mitral regurgitation (MR) on patient mortality, morbidity, and quality of life is widely...